Details for New Drug Application (NDA): 087695
✉ Email this page to a colleague
NDA 087695 describes FOLEX, which is a drug marketed by Pharmacia And Upjohn and is included in four NDAs. Additional details are available on the FOLEX profile page.
The generic ingredient in FOLEX is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
The generic ingredient in FOLEX is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
Summary for 087695
| Tradename: | FOLEX |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | methotrexate sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 25MG BASE/VIAL | ||||
| Approval Date: | Apr 8, 1983 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG BASE/VIAL | ||||
| Approval Date: | Apr 8, 1983 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/VIAL | ||||
| Approval Date: | Apr 8, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
